Outlook Therapeutics Inc. buy BiotechBee
Start price
06.02.23
/
60%
€1.18
Target price
31.12.25
€2.00
Performance (%)
-15.64%
End price
05.05.23
€1.00
Summary
This prediction ended on 05.05.23 with a price of €1.00. The price of Outlook Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.64%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Outlook Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% | 46.264% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% | 72.335% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% | 52.282% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% | 55.100% |
According to BiotechBee what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year